FOXO Technologies Inc. (NYSEAMERICAN:FOXO) Short Interest Down 49.2% in March

FOXO Technologies Inc. (NYSEAMERICAN:FOXO) saw a large drop in short interest in March. As of March 15th, there was short interest totalling 960,200 shares, a drop of 49.2% from the February 28th total of 1,890,000 shares. Currently, 3.3% of the shares of the stock are short sold. Based on an average daily volume of 7,110,000 shares, the short-interest ratio is currently 0.1 days.

Hedge Funds Weigh In On FOXO Technologies

An institutional investor recently bought a new position in FOXO Technologies stock. Jane Street Group LLC acquired a new stake in FOXO Technologies Inc. (NYSEAMERICAN:FOXO) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 117,047 shares of the company’s stock, valued at approximately $34,000. Jane Street Group LLC owned 0.67% of FOXO Technologies at the end of the most recent quarter. 44.89% of the stock is owned by hedge funds and other institutional investors.

FOXO Technologies Stock Down 8.0 %

FOXO traded down $0.01 on Friday, hitting $0.13. 1,365,433 shares of the company’s stock were exchanged, compared to its average volume of 14,627,025. FOXO Technologies has a fifty-two week low of $0.13 and a fifty-two week high of $1.30. The firm’s 50-day simple moving average is $0.27.

FOXO Technologies Company Profile

FOXO Technologies Inc engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging.